On the Intergenerational Transmission of Health Inequality

Cumulating evidence from social science has indicated the intergenerational transmission of inequality is majorly derived from the economic imbalance. In line with this, the same thing happens in health, and emerging evidence has been documenting its transmissible property. No matter the genetic or non-genetic causes, health inequality inevitably plays its role in contributing to the underlying health-associated despoliation in life. Each individual shows an eventual health state where equality and inequality reach a time-dependent temporary condition in which the balancing point fluctuates back and forth. To promote the overall health status, it is crucial to promote and optimize the positive health characteristics to get equilibrium between positive and negative. This review discussed the underlying mechanisms of intergenerational transmission of health inequality by focusing on different types of contributors to the inequality and providing prospective insights into the potentially beneficial strategies that can optimize overall individual health

Acute Delta Hepatitis in Italy spanning three decades (1991–2019): Evidence for the effectiveness of the hepatitis B vaccination campaign

Updated incidence data of acute Delta virus hepatitis (HDV) are lacking worldwide. Our aim was to evaluate incidence of and risk factors for acute HDV in Italy after the introduction of the compulsory vaccination against hepatitis B virus (HBV) in 1991. Data were obtained from the National Surveillance System of acute viral hepatitis (SEIEVA). Independent predictors of HDV were assessed by logistic-regression analysis. The incidence of acute HDV per 1-million population declined from 3.2 cases in 1987 to 0.04 in 2019, parallel to that of acute HBV per 100,000 from 10.0 to 0.39 cases during the same period. The median age of cases increased from 27 years in the decade 1991-1999 to 44 years in the decade 2010-2019 (p < .001). Over the same period, the male/female ratio decreased from 3.8 to 2.1, the proportion of coinfections increased from 55% to 75% (p = .003) and that of HBsAg positive acute hepatitis tested for by IgM anti-HDV linearly decreased from 50.1% to 34.1% (p < .001). People born abroad accounted for 24.6% of cases in 2004-2010 and 32.1% in 2011-2019. In the period 2010-2019, risky sexual behaviour (O.R. 4.2; 95%CI: 1.4-12.8) was the sole independent predictor of acute HDV; conversely intravenous drug use was no longer associated (O.R. 1.25; 95%CI: 0.15-10.22) with this. In conclusion, HBV vaccination was an effective measure to control acute HDV. Intravenous drug use is no longer an efficient mode of HDV spread. Testing for IgM-anti HDV is a grey area requiring alert. Acute HDV in foreigners should be monitored in the years to come

Effect of Seat Tube Angle and Exercise Intensity on Muscle Activity Patterns in Cyclists

International Journal of Exercise Science 10(8): 1145-1156, 2017. Previous studies have reported improved efficiency at steeper seat tube angle (STA) during ergometer cycling; however, neuromuscular mechanisms have yet to be fully determined. The current study investigated effects of STA on lower limb EMG activity at varying exercise intensities. Cyclists (n=11) were tested at 2 workloads; 160W and an individualised workload (IWL) equivalent to lactate threshold (TLac) minus 10%δ (derived from maximal incremental data), using 3 STA (70, 75 and 80°). Electromyographic data from Vastus Medialis (VM), Rectus Femoris (RF), Vastus Lateralis (VL) and Biceps Femoris (BF) were assessed. The timing and magnitude of activation were quantified and analysed using a two-way ANOVA. STA had significant (P \u3c 0.05) effects on timing of onset and offset of VM, timing of offset of VL, and angle at peak for RF, all occurring later at 80 vs. 70° STA at IWL. In RF, increased activity occurred during the first 108° of the crank cycle at 80 vs. 70° at IWL (P \u3c 0.01). As most of the power in the pedal stroke is generated during the mid-section of the down-stroke, movement of the activation range of knee extensors into the predominantly power phase of the pedal stroke would potentially account for increased efficiency and decreased cardio-respiratory costs. Greater activity of bi-articular RF, in the first 108º of the crank cycle at IWL (80 vs. 70º) may more closely resemble the pelvic stabilising activity of RF in running biomechanics; and potentially explain the more effective transition from cycling to running reported in triathletes using steeper STA

Human-animal Hybrid Embryo Experiment: Gospel versus Disaster?

The academic debate on the study of human and animal embryos has never stopped. Despite the great expectations of scientists, the human-animal embryo hybrid experiment costs a lot and requires high technology as the endorsement, and is highly questioned internationally. Human and animal embryo experiments are contrary to ethics, and the results of cross-species hybrid embryos are unpredictable, or cause zoonotic diseases or human catastrophe. The human and animal parts of the human “chimera” embryo will develop independently, and the DNA of the two will not be mixed. It is still far from being able to use the organs obtained from the mixed embryos of humans and animals to carry out organ transplants to save more lives

Combination of two-dimensional gel electrophoresis and a fluorescent carboxyfluorescein-diacetate-labeled cisplatin analogue allows the identification of intracellular cisplatin-protein adducts

Cisplatin is one of the most widely used anticancer agents, but a major problem for successful chemotherapy is the development of drug resistance of tumor cells against cisplatin. Resistance to cisplatin is a multifactorial problem. A method to detect and identify intracellular cisplatin-protein adducts was developed using a fluorescent carboxyfluoresceindiacetate-labeled cisplatin analogue (CFDA-cisplatin), 2DE, and ESI-MS/MS. We identified several CFDA-cisplatin-protein adducts including members of the protein disulfide isomerase family (PDI). These are the first results of the detection of intracellular CFDA-cisplatin-protein adducts, which may help to understand the resistance mechanism of cisplatin